EMD has a great chance because of the data they own. IHL is not over valued at all, they target conditions with no approved treatment so getting FDA approval would be easier. The board is second to none.
- Forums
- ASX - By Stock
- EMD
- Ann: Global Pharmaceutical Expert joins Advisory Board
Ann: Global Pharmaceutical Expert joins Advisory Board, page-5
Featured News
Add EMD (ASX) to my watchlist
|
|||||
Last
4.7¢ |
Change
0.002(4.44%) |
Mkt cap ! $19.22M |
Open | High | Low | Value | Volume |
4.7¢ | 4.7¢ | 4.7¢ | $2.289K | 48.70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 217 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 44999 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 217 | 0.046 |
3 | 28333 | 0.045 |
2 | 47577 | 0.044 |
2 | 54535 | 0.043 |
1 | 100000 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 44999 | 2 |
0.048 | 122656 | 2 |
0.050 | 186139 | 3 |
0.055 | 76850 | 1 |
0.057 | 99729 | 1 |
Last trade - 10.02am 25/07/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online